Star Imaging and Path Lab Limited responded to BSE's inquiry regarding significant share price movement, confirming full regulatory compliance.
The company stated no undisclosed material information exists and attributed price volatility to market conditions and speculative activity.
Management confirmed promoters and key personnel have not traded company securities recently and reiterated commitment to disclosure norms.